Tofacitinib Tofajak Tablets 5mg

Get a Price/Quote

MOQ : 100 Boxes

Tofacitinib Tofajak Tablets 5mg Specification

Dosage Form
Tablet

Salt Composition
Tofacitinib

Pacakaging (Quantity Per Box)
60 Tablets

Life Span
Check expiry on box; generally 2-3 years from manufacture

Packaging Type
Box

Indication
Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis

Brand Name
Cipla

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Tofacitinib

Physical Form
Tablet

Function
Immunomodulator (JAK inhibitor)

Recommended For
Adults with rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis (as per prescription)

Dosage
5mg per tablet

Dosage Guidelines
As directed by physician

Quantity
60 Tablets

Storage Instructions
Store in a cool, dry place, away from direct sunlight

Color
Not specified (typical is white to off-white)

Strength
5mg

Side Effects
Risk of infection, headache, high blood pressure, liver enzyme increase

Contraindications
Hypersensitivity to Tofacitinib or excipients

Prescription Required
Yes

Shape
Not specified (typically round or oval)

Regulatory Approval
Available in multiple countries (Canada, EU, UK, USA, Australia)

Route of Administration
Oral

Warning
Not recommended in patients with severe hepatic impairment unless prescribed

Tofacitinib Tofajak Tablets 5mg Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Tofacitinib Tofajak Tablets 5mg About

Unlock superior immune health management with Cipla's Tofacitinib Tofajak Tablets 5mg. Designed for adults, these exceptional tablets provide targeted relief in rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Take advantage of our special rate with advance purchase options and regulatory approval across major markets including Canada, EU, UK, USA, and Australia. Each box contains 60 ravishingly effective oral tablets, expertly formulated for maximum efficacy as a JAK inhibitor. Prescription required. Store safely-see box for recommended storage and expiry details. Elevate your treatment with a brand trusted worldwide.

Exceptional Immunomodulator for Advanced Care

Tofacitinib Tofajak Tablets 5mg are used orally in adults, under physician supervision, to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The primary competitive advantages include broad regulatory approval and a proven track record as a superior JAK inhibitor. Provided in secure, tamper-proof packaging of 60 tablets, these tablets ensure consistent dosage and convenience. Additional features include a long shelf life and clear dosage guidance, making Tofajakin an exceptional choice for long-term management.

Regulatory Compliance and Efficient Supply Solution

Certified for use in multiple top-tier markets, Tofacitinib Tofajak Tablets offer robust market value and widespread acceptance. Payment terms are flexible, accommodating various customer needs, while sample availability ensures trial before commitment. Reliable global delivery and steady supply help maintain uninterrupted treatment. All packaging displays expiry and regulatory information, ensuring both professionals and users enjoy confidence and convenience when ordering and receiving their treatments.

FAQ's of Tofacitinib Tofajak Tablets 5mg:

Q: How should Tofacitinib Tofajak Tablets 5mg be taken?

A: Tofacitinib Tofajak Tablets should be taken orally as directed by your physician. Do not exceed the prescribed dosage, and always follow storage instructions to maintain tablet efficacy.

Q: What are the main uses of Tofacitinib Tofajak Tablets 5mg?

A: These tablets are primarily recommended for adults diagnosed with rheumatoid arthritis, psoriatic arthritis, or ulcerative colitis, as prescribed by a medical professional.

Q: When can I expect delivery of Tofacitinib Tofajak Tablets after purchase?

A: Delivery timelines depend on your location and the supplier, but efficient global supply practices usually ensure prompt shipment to most markets where regulatory approval exists.

Q: Where are Tofacitinib Tofajak Tablets available and approved for use?

A: Tofacitinib Tofajak Tablets are available and approved in several countries, including Canada, the EU, UK, USA, and Australia, with reliable distribution channels in these regions.

Q: What is the benefit of advance purchase at a special rate for Tofacitinib Tofajak Tablets?

A: Advance purchase at a special rate allows you to secure continued treatment supply at optimal pricing and minimizes the risk of stock shortages.

Q: What precautions should be taken when using this medication?

A: This medication should not be used by individuals with hypersensitivity to Tofacitinib, and it is not recommended for patients with severe hepatic impairment unless prescribed by a physician. Always consult your doctor for suitability.

Tell us about your requirement